ADMA Biologics, Inc (NASDAQ:ADMA) Accelerates Buybacks While Technicals Signal Near-Term Rebound
![]() |
Balance-sheet strength and an accelerated share-repurchase program sit alongside oversold technicals, creating a setup that favors a measured recovery attempt in the near term. Operational margin expansion and strong cash generation underpin the valuation case. |








